Latest News

Date Title Topic
12 Mar 2015 FDA Approves First Therapy for High-Risk Neuroblastoma Cancer in Special Situations - Anticancer agents & Biologic therapy
10 Mar 2015 Rare Cancers Europe Press Release: Improving the Organisation of Healthcare for Rare Cancer Patients
10 Mar 2015 FDA Approves First Biosimilar Product in the USA Palliative and supportive care
09 Mar 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Pegfilgrastim (Ristempa) Palliative and supportive care
06 Mar 2015 ESMO South-East Asia Summit: Meeting Resources
06 Mar 2015 FDA Expands Approved Use of Nivolumab to Squamous NSCLC Lung and other thoracic tumours - Immuno-oncology
05 Mar 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Panitumumab Gastrointestinal cancers - Anticancer agents & Biologic therapy
04 Mar 2015 Whole Genome Sequencing of Pancreatic Ductal Adenocarcinomas Translational research - Gastrointestinal cancers
03 Mar 2015 ICHNO 2015: Meeting Resources
03 Mar 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Bevacizumab Gynaecologic malignancies - Anticancer agents & Biologic therapy
02 Mar 2015 Adjuvant VEGF Inhibitors, Sorafenib or Sunitinib, do not Improve Outcomes in Resected Locally-Advanced Renal Carcinoma Genitourinary cancers - Anticancer agents & Biologic therapy
27 Feb 2015 European Medicines Agency Recommends Granting a Conditional Marketing Authorisation for Ceritinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
25 Feb 2015 FDA Approves Panobinostat for Treatment of Multiple Myeloma Haematologic malignancies - Anticancer agents & Biologic therapy
23 Feb 2015 FDA Permits Marketing of First Direct-to-Consumer Genetic Carrier Test for Bloom Syndrome Epidemiology/Etiology/Cancer Prevention
20 Feb 2015 New HPV Vaccine Offers Greater Protection Against Cervical Cancer Than Current Vaccine Epidemiology/Etiology/Cancer Prevention - Gynaecologic malignancies